Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers
NCT ID: NCT02003430
Last Updated: 2018-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2013-09-30
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adaptive Radiotherapy in Patients With Gynecological Tumors
NCT06230549
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
NCT02091050
Geriatric-oncological Study on Quality of Life and Independence After Radiotherapy
NCT05187845
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
NCT05351294
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
NCT05994300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
≥65 years old
20 patients greater than or equal to 65 years of age
No interventions assigned to this group
<65 years old
20 patients less than 65 years of age
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of cervical, vaginal, vulvar, or endometrial cancer with either pelvic radiotherapy or chemoradiotherapy planned as part of standard treatment.
* Consented for receipt of External Beam Radiation Therapy (EBRT) at the University of North Carolina Chapel Hill
* Ability to read English (required for CGA)
* Curative treatment intent as defined by their radiation oncologist
* Negative serum pregnancy test in women of childbearing potential
Exclusion Criteria
* Incurable cancer as defined by their radiation oncologist
* Planned radiation for palliative intent only
* Inability to complete the I-ADL section of the CGA
* Prior radiation to areas targeted by radiotherapy within this study
* Other active, invasive malignancy requiring active ongoing therapy during their radiotherapy with the exception of:
* Localized squamous cell carcinoma of the skin
* Basal-cell carcinoma of the skin
* Other malignancies requiring locally ablative therapy only
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahesh Varia, MD, ChB
Role: PRINCIPAL_INVESTIGATOR
Department of Radiation Oncology, University of North Carolina Chapel Hill
Noam VanderWalde, MD
Role: STUDY_DIRECTOR
Department of Radiation Oncology, Unverisity of North Carolina Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNC Department of Radiation Oncology Clinic
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCCC1321
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.